1. Cancer Statistics Review, 1975-2013 – Previous Version – SEER Cancer Statistics Review. SEER. Available from: https://www.seer.cancer.gov/archive/csr/1975_2013/index.html. [Last accessed on 2019 Jan 22].
2. Localized High-Risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults: An Integrating Approach Comprising Standard vs. Histotype-Tailored Neoadjuvant Chemotherapy – Full Text View – ClinicalTrials.gov. Available from: https://www.clinicaltrials.gov/ct2/show/NCT01710176. [Last accessed on 2019 Jan 17].
3. A Scandinavian Sarcoma Group Protocol for Patients with High-Risk Soft Tissue Sarcoma of the Extremities and Trunk Wall – Full Text View – ClinicalTrials.gov. Available from: https://www.clinicaltrials.gov/ct2/show/NCT00790244. [Last accessed on 2019 Jan 17].
4. A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity – Full Text View – ClinicalTrials.gov. Available from: https://www.clinicaltrials.gov/ct2/show/NCT03092323. [Last accessed on 2019 Jan 17].
5. Hypofractionated Radiotherapy with Sequential Chemotherapy in Primary Unresectable or Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall – Full Text View – ClinicalTrials.gov. Available from: https://www.clinicaltrials.gov/ct2/show/NCT03651375. [Last accessed on 2019 Jan 17].